AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Sharma, P Chawla, HPS Panchagnula, R
Citation: P. Sharma et al., LC determination of cephalosporins in in vitro rat intestinal sac absorption model, J PHARM B, 27(1-2), 2002, pp. 39-50

Authors: Pillai, O Dhanikula, AB Panchagnula, R
Citation: O. Pillai et al., Drug delivery: an odyssey of 100 years, CURR OP C B, 5(4), 2001, pp. 439-446

Authors: Pillai, O Panchagnula, R
Citation: O. Pillai et R. Panchagnula, Polymers in drug delivery, CURR OP C B, 5(4), 2001, pp. 447-451

Authors: Pillai, O Panchagnula, R
Citation: O. Pillai et R. Panchagnula, Insulin therapies - past, present and future, DRUG DISC T, 6(20), 2001, pp. 1056-1061

Authors: Dhanikula, AB Panchagnula, R Singh, I Kaur, KJ Kaul, CL Sekhon, JS
Citation: Ab. Dhanikula et al., Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m(2) vs. 175 mg/m(2), METH FIND E, 23(2), 2001, pp. 93-98

Authors: Panchagnula, R Salve, PS Thomas, NS Jain, AK Ramarao, P
Citation: R. Panchagnula et al., Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin, INT J PHARM, 219(1-2), 2001, pp. 95-105

Authors: Pillai, O Nair, V Jain, AK Thomas, NS Panchagnula, R
Citation: O. Pillai et al., Noninvasive transdermal delivery of peptides and proteins, DRUG FUTURE, 26(8), 2001, pp. 779-791

Authors: Panchagnula, R Kini, U
Citation: R. Panchagnula et U. Kini, Intravascular lobular capillary hemangioma arising in an hemangioma: A much disputed entity, OTO H N SUR, 125(5), 2001, pp. 574-575

Authors: Agrawal, S Kaul, CL Panchagnula, R
Citation: S. Agrawal et al., Bioequivalence of isoniazid in a two drug fixed dose combination and in a single drug dosage form, PHARMAZIE, 56(8), 2001, pp. 636-639

Authors: Sood, A Panchagnula, R
Citation: A. Sood et R. Panchagnula, Peroral route: An opportunity for protein and peptide drug delivery, CHEM REV, 101(11), 2001, pp. 3275-3303

Authors: Panchagnula, R Pillai, O Nair, VB Ramarao, P
Citation: R. Panchagnula et al., Transdermal iontophoresis revisited, CURR OP C B, 4(4), 2000, pp. 468-473

Authors: Gandhi, R Sharma, P Chawla, HPS Kaul, CL Panchagnula, R
Citation: R. Gandhi et al., HPLC analysis of tricyclic antidepressants in skin diffusion studies, STP PHARM S, 10(3), 2000, pp. 234-238

Authors: Panchagnula, R Agrawal, S Kaur, KJ Singh, I Kaul, CL
Citation: R. Panchagnula et al., Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol, INT J TUBE, 4(12), 2000, pp. 1169-1172

Authors: Gandhi, R Kaul, CL Panchagnula, R
Citation: R. Gandhi et al., Validated LC method for in-vitro analysis of azithromycin using electrochemical detection, J PHARM B, 23(6), 2000, pp. 1073-1078

Authors: Panchagnula, R Kaur, KJ Singh, I Kaul, CL
Citation: R. Panchagnula et al., Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations, METH FIND E, 22(9), 2000, pp. 689-694

Authors: Panchagnula, R Jain, AK Pillai, O Jaiswal, J
Citation: R. Panchagnula et al., Nicotine transdermal systems: Pharmaceutical and clinical aspects, METH FIND E, 22(5), 2000, pp. 299-308

Authors: Jain, AK Panchagnula, R
Citation: Ak. Jain et R. Panchagnula, Skeletal drug delivery systems, INT J PHARM, 206(1-2), 2000, pp. 1-12

Authors: Panchagnula, R Thomas, NS
Citation: R. Panchagnula et Ns. Thomas, Biopharmaceutics and pharmacokinetics in drug research, INT J PHARM, 201(2), 2000, pp. 131-150

Authors: Gandhi, R Kaul, CL Panchagnula, R
Citation: R. Gandhi et al., Extrusion and spheronization in the development of oral controlled-releasedosage forms, PHARM SCI T, 2(4), 1999, pp. 160-170

Authors: Sood, A Panchagnula, R
Citation: A. Sood et R. Panchagnula, Role of dissolution studies in controlled release drug delivery systems, STP PHARM S, 9(2), 1999, pp. 157-168

Authors: Panchagnula, R Kaur, KJ Singh, I Kaul, CL
Citation: R. Panchagnula et al., The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO, INT J TUBE, 3(11), 1999, pp. S336-S342

Authors: Iseman, MD Fourie, PB Mitchison, DA Kaul, C Wang, J Kenyon, T Panchagnula, R Pillai, C",Boman,Mika
Citation: Md. Iseman et al., Panel discussion II, INT J TUBE, 3(11), 1999, pp. S351-S352

Authors: Panchagnula, R Sood, A Sharda, N Kaur, K Kaul, CL
Citation: R. Panchagnula et al., Determination of rifampicin and its main metabolite in plasma and urine inpresence of pyrazinamide and isoniazid by HPLC method, J PHARM B, 18(6), 1999, pp. 1013-1020

Authors: Panchagnula, R Singh, I Kaur, KJ Kaul, CL
Citation: R. Panchagnula et al., Bioequivalence study of rifampicin in fixed-dose combination of rifampicinand isoniazid vs. separate formulations, METH FIND E, 21(9), 1999, pp. 625-628

Authors: Pillai, O Nair, V Poduri, R Panchagnula, R
Citation: O. Pillai et al., Transdermal iontophoresis. Part II: Peptide and protein delivery, METH FIND E, 21(3), 1999, pp. 229-240
Risultati: 1-25 | 26-28